BridgeBio Pharma Inc (BBIO)
26.50
+0.28
(+1.09%)
USD |
NASDAQ |
Dec 20, 16:00
26.49
0.00 (0.00%)
After-Hours: 20:00
BridgeBio Pharma Profit Margin (Quarterly): -5.93K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 25.22% |
| Alnylam Pharmaceuticals Inc | -22.27% |
| Cassava Sciences Inc | -- |
| Regeneron Pharmaceuticals Inc | 36.03% |
| Vertex Pharmaceuticals Inc | 37.71% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -62.51% |
| Return on Invested Capital | -80.46% |
| Gross Profit Margin (Quarterly) | 78.11% |
| Operating Margin (Quarterly) | -6.85K% |
| Return on Net Operating Assets | -471.4% |